Long noncoding RNA LERFS negatively regulates rheumatoid synovial aggression and proliferation
Yaoyao Zou1, Siqi Xu1, Youjun Xiao1
1Department of Rheumatology and Clinical Immunology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
The Journal of Clinical Investigation
|September 11, 2018
Summary
A novel long noncoding RNA, LERFS, regulates fibroblast-like synoviocytes in rheumatoid arthritis (RA). Decreased LERFS levels promote RA progression, suggesting LERFS as a potential therapeutic target.
Area of Science:
- Molecular Biology
- Rheumatology
- Genetics
Background:
- Fibroblast-like synoviocytes (FLSs) drive joint destruction in rheumatoid arthritis (RA).
- The function of long noncoding RNAs (lncRNAs) in RA pathogenesis is not well understood.
Purpose of the Study:
- To identify and characterize novel lncRNAs involved in RA pathogenesis.
- To investigate the regulatory role of LERFS in FLS function and its potential as a therapeutic target in RA.
Main Methods:
- Identification of LERFS (lowly expressed in rheumatoid fibroblast-like synoviocytes) as a novel lncRNA.
- Investigated the interaction of LERFS with heterogeneous nuclear ribonucleoprotein Q (hnRNP Q).
- Assessed the impact of LERFS on FLS migration, invasion, and proliferation by targeting RhoA, Rac1, and CDC42 mRNA stability and translation.
Main Results:
- LERFS negatively regulates FLS migration, invasion, and proliferation by modulating the stability/translation of RhoA, Rac1, and CDC42 mRNAs via hnRNP Q.
- RA FLSs exhibit decreased LERFS levels, leading to reduced LERFS-hnRNP Q complex formation.
- This reduction enhances target mRNA stability/translation, promoting FLS aggression and contributing to joint destruction in RA.
Conclusions:
- Reduced synovial LERFS expression is implicated in RA pathogenesis and joint damage.
- Targeting the lncRNA LERFS presents a potential therapeutic strategy for rheumatoid arthritis.
Related Concept Videos
Negative Regulator Molecules
38.5K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.5K
Aggression
30.4K
Humans engage in aggression when they seek to cause harm or pain to another person. Aggression takes two forms depending on one’s motives: hostile or instrumental. Hostile aggression is motivated by feelings of anger with intent to cause pain; a fight in a bar with a stranger is an example of hostile aggression. In contrast, instrumental aggression is motivated by achieving a goal and does not necessarily involve intent to cause pain (Berkowitz, 1993); a contract killer who murders for...
30.4K
Epigenetic Regulation
33.8K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.8K
Structural Joints: Synovial Joints
7.0K
Synovial joints are the most common type of joint in the body. A key structural characteristic for a synovial joint is the presence of a joint cavity. This fluid-filled space is where the articulating surfaces of the bones contact each other. Also, unlike fibrous or cartilaginous joints, the articulating bone surfaces at a synovial joint are not directly connected to each other with fibrous connective tissue or cartilage. This gives the bones of a synovial joint the ability to move smoothly...
7.0K
Abnormal Proliferation
5.2K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.2K
Development of the Limb Synovial Joints
2.4K
Joints form during embryonic development in conjunction with the formation and growth of the associated bones. The embryonic tissue that gives rise to all bones, cartilage, and connective tissues of the body is called mesenchyme.
The mesenchymal stem cells differentiate into chondrocytes that form the hyaline cartilage, and later the cartilaginous model of the bone. This model further transforms into a bone. This process is known as endochondral ossification.
During development, the limbs...
The mesenchymal stem cells differentiate into chondrocytes that form the hyaline cartilage, and later the cartilaginous model of the bone. This model further transforms into a bone. This process is known as endochondral ossification.
During development, the limbs...
2.4K


